Open AccessEfficacy of a Monthly Compared to 3-Monthly Depot GnRH Analogue (Goserelin) in the Treatment of Children with Central Precocious Puberty
Author(s) -
Helen B. Isaac,
Leena Patel,
Stacy L. Meyer,
C. M. Hall,
C. F. Cusick,
David A. Price,
Peter Clayton
Publication year - 2007
Publication title -
hormone research in paediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.816
H-Index - 89
eISSN - 1663-2826
pISSN - 1663-2818
DOI - 10.1159/000100579
Subject(s) - medicine , goserelin , central precocious puberty , body mass index , endocrinology , precocious puberty , etiology , hormone , cancer , breast cancer
To compare the efficacy of goserelin 10.8 mg (Zoladex LA-ZLA) administered 9-12 weekly with 3.6 mg (Zoladex-Z) given monthly in suppressing pubertal development, and effect on body mass index (BMI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom